Fig. 4.
Fig. 4. Incidence of EBV-LPD. / Incidence of EBV-LPD (n = 10) after TCD-allogeneic SCT combined with ATG (n = 24), TCD-SCT without ATG (n = 61), and non–TCD-SCT (n = 65).

Incidence of EBV-LPD.

Incidence of EBV-LPD (n = 10) after TCD-allogeneic SCT combined with ATG (n = 24), TCD-SCT without ATG (n = 61), and non–TCD-SCT (n = 65).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal